Hong Kong Pharma Digital Technology Holdings Limited (HKPD) P/E Ratio History
Historical price-to-earnings valuation from 2026 to 2026
Loading P/E history...
HKPD Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
Compared to the Industrials sector median P/E of 25.5x, HKPD trades at a 935% discount to its sector peers. The sector includes 413 companies with P/E ratios ranging from 0.0x to 185.3x.
Relative to the broader market, HKPD trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our HKPD DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
HKPD P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $589M | 9.2Lowest | - | +225%Best | |
| $7B | 50.3 | - | -4% | |
| $124M | 24.6 | - | +125% | |
| $4B | 43.2 | 1.22Best | -10% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
See HKPD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HKPD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare HKPD vs SPIR
Side-by-side business, growth, and profitability comparison vs Spire Global, Inc..
Start ComparisonHKPD — Frequently Asked Questions
Quick answers to the most common questions about buying HKPD stock.
Is HKPD stock overvalued or undervalued?
HKPD current P/E: -213.3x. 5-year average P/E: N/A. Percentile: N/A.
How does HKPD's valuation compare to peers?
Hong Kong Pharma Digital Technology Holdings Limited P/E of -213.3x compares to sector median of 25.5x. The discount suggests lower growth expectations or higher risk.
What is HKPD's PEG ratio?
HKPD PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2026-2026.